• Dooley, K. E., Denti, P., Martinson, N., Cohn, S., Mashabela, F., Hoffmann, J., Haas, D. W., Hull, J., Msandiwa, R., Castel, S., Wiesner, L., Chaisson, R. E., & McIlleron, H. (2015). Pharmacokinetics of Efavirenz and Treatment of HIV-1 Among Pregnant Women With and Without Tuberculosis Coinfection. Journal of Infectious Diseases, 211(2), 197–205. https://doi.org/10.1093/infdis/jiu429
     
  • du Plessis, L. H., Govender, K., Denti, P., & Wiesner, L. (2015). In vivo efficacy and bioavailability of lumefantrine: Evaluating the application of Pheroid technology. European Journal of Pharmaceutics and Biopharmaceutics, 97, 68–77. https://doi.org/10.1016/j.ejpb.2015.10.001
     
  • Denti, P., Jeremiah, K., Chigutsa, E., Faurholt-Jepsen, D., PrayGod, G., Range, N., Castel, S., Wiesner, L., Hagen, C. M., Christiansen, M., Changalucha, J., McIlleron, H., Friis, H., & Andersen, A. B. (2015). Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania. PLOS ONE,10(10), e0141002. https://doi.org/10.1371/journal.pone.0141002